Cargando…

Sex differences in associations of comorbidities with incident cardiovascular disease: focus on absolute risk

AIM: To examine sex differences in associations of obesity, type-2 diabetes, hypertension, and atrial fibrillation (AF) with incident cardiovascular disease (CVD), focusing on absolute risk measures. METHODS AND RESULTS: We included a total of 7994 individuals (mean age 49.1 years; 51.2% women) with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dronkers, Just, Meems, Laura M G, van Veldhuisen, Dirk J, Meyer, Sven, Kieneker, Lyanne M, Gansevoort, Ron T, Bakker, Stephan J L, Rienstra, Michiel, de Boer, Rudolf A, Suthahar, Navin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9242082/ https://www.ncbi.nlm.nih.gov/pubmed/35919118 http://dx.doi.org/10.1093/ehjopen/oeac017

Ejemplares similares

Relative fat mass, a new index of adiposity, is strongly associated with incident heart failure: data from PREVEND
por: Suthahar, Navin, et al.
Publicado: (2022)

Relationship between body mass index, cardiovascular biomarkers and incident heart failure
por: Suthahar, Navin, et al.
Publicado: (2021)

Atrial fibrillation detected at screening is not a benign condition: outcomes in screen-detected versus clinically detected atrial fibrillation. Results from the Prevention of Renal and Vascular End-stage Disease (PREVEND) study
por: Zwartkruis, Victor W, et al.
Publicado: (2021)

Urinary albumin excretion and cancer risk: the PREVEND cohort study
por: Luo, Li, et al.
Publicado: (2023)

Plasma potassium, diuretic use and risk of developing chronic kidney disease in a predominantly White population
por: Kieneker, Lyanne M., et al.
Publicado: (2017)

Sex‐related differences in contemporary biomarkers for heart failure: a review
por: Suthahar, Navin, et al.
Publicado: (2020)

Plasma Proenkephalin and Poor Long-Term Outcome in Renal Transplant Recipients
por: Kieneker, Lyanne M., et al.
Publicado: (2017)

Separating the effects of 24-hour urinary chloride and sodium excretion on blood pressure and risk of hypertension: Results from PREVEND
por: van der Leeuw, Joep, et al.
Publicado: (2020)

Urinary Calcium Excretion and Risk of Chronic Kidney Disease in the General Population
por: Taylor, Jacob M., et al.
Publicado: (2016)

High selenium levels associate with reduced risk of mortality and new‐onset heart failure: data from PREVEND
por: Al‐Mubarak, Ali A., et al.
Publicado: (2022)

Self‐Reported Smoking, Urine Cotinine, and Risk of Cardiovascular Disease: Findings From the PREVEND (Prevention of Renal and Vascular End‐Stage Disease) Prospective Cohort Study
por: Kunutsor, Setor K., et al.
Publicado: (2018)

Albuminuria and the risk of cancer: the Stockholm CREAtinine Measurements (SCREAM) project
por: Luo, Li, et al.
Publicado: (2023)

Vitamin B6, Inflammation, and Cardiovascular Outcome in a Population-Based Cohort: The Prevention of Renal and Vascular End-Stage Disease (PREVEND) Study
por: Minović, Isidor, et al.
Publicado: (2020)

Bariatric surgery and cardiovascular disease: a systematic review and meta-analysis
por: van Veldhuisen, Sophie L, et al.
Publicado: (2022)

A Sex-Specific Comparative Analysis of Oxidative Stress Biomarkers Predicting the Risk of Cardiovascular Events and All-Cause Mortality in the General Population: A Prospective Cohort Study
por: Bourgonje, Martin F., et al.
Publicado: (2023)

The emerging plasma biomarker Dickkopf-3 (DKK3) and its association with renal and cardiovascular disease in the general population
por: Piek, Arnold, et al.
Publicado: (2021)

Connecting epicardial adipose tissue and heart failure with preserved ejection fraction: mechanisms, management and modern perspectives
por: van Woerden, Gijs, et al.
Publicado: (2022)

Combined low vitamin D and K status amplifies mortality risk: a prospective study
por: van Ballegooijen, Adriana J., et al.
Publicado: (2020)

What should the C (‘congestive heart failure’) represent in the CHA(2)DS(2)‐VASc score?
por: Mulder, Bart A., et al.
Publicado: (2020)

Population-Based Limits of Urine Creatinine Excretion
por: Kestenbaum, Bryan, et al.
Publicado: (2022)

Cardiovascular and renal multimorbidity increase risk of atrial fibrillation in the PREVEND cohort
por: Van Deutekom, Colinda, et al.
Publicado: (2023)

Clustering of cardiovascular and renal comorbidities and risk of incident atrial fibrillation in the community-based PREVEND cohort
por: Van Deutekom, C, et al.
Publicado: (2023)

Diffuse Myocardial Fibrosis on Cardiac Magnetic Resonance Imaging Is Related to Galectin-3 and Predicts Outcome in Heart Failure
por: Screever, Elles M., et al.
Publicado: (2023)

Circulating Total Bilirubin and Future Risk of Hypertension in the General Population: The Prevention of Renal and Vascular End‐Stage Disease (PREVEND) Prospective Study and a Mendelian Randomization Approach
por: Kunutsor, Setor K., et al.
Publicado: (2017)

Left atrial volume and left ventricular mass indices in heart failure with preserved and reduced ejection fraction
por: Gehlken, Carolin, et al.
Publicado: (2021)

Preoperative cardiac screening using NT-proBNP in obese patients 50 years and older undergoing bariatric surgery: a study of 310 consecutive patients()
por: van Veldhuisen, Sophie L., et al.
Publicado: (2021)

Association of Cardiometabolic Disease With Cancer in the Community
por: Liu, Elizabeth E., et al.
Publicado: (2022)

Reply: Imaging-Based Obesity Assessment for Risk Factor Stratification and Prognostication in Malignancy
por: Liu, Elizabeth E., et al.
Publicado: (2022)

Plasma C-Peptide and Risk of Developing Type 2 Diabetes in the General Population
por: Sokooti, Sara, et al.
Publicado: (2020)

Systemic Oxidative Stress, Aging and the Risk of Cardiovascular Events in the General Female Population
por: Bourgonje, Martin F., et al.
Publicado: (2021)

Circulating total bilirubin and risk of non-alcoholic fatty liver disease in the PREVEND study: observational findings and a Mendelian randomization study
por: Kunutsor, Setor K., et al.
Publicado: (2019)

Proenkephalin and the risk of new‐onset heart failure: data from prevention of renal and vascular end‐stage disease
por: Emmens, Johanna E., et al.
Publicado: (2021)

Progress in heart failure management in the Netherlands and beyond: long-term commitment to deliver high-quality research and patient care
por: Meems, L. M. G., et al.
Publicado: (2020)

Plasma calcidiol, calcitriol, and parathyroid hormone and risk of new onset heart failure in a population‐based cohort study
por: Meems, Laura M. G., et al.
Publicado: (2016)

From Inflammation to Fibrosis—Molecular and Cellular Mechanisms of Myocardial Tissue Remodelling and Perspectives on Differential Treatment Opportunities
por: Suthahar, Navin, et al.
Publicado: (2017)

Incident heart failure risk after bariatric surgery: the role of epicardial fat
por: van Woerden, Gijs, et al.
Publicado: (2020)

A Genome-Wide Association Study of Circulating Galectin-3
por: de Boer, Rudolf A., et al.
Publicado: (2012)

A combined bioinformatics, experimental and clinical approach to identify novel cardiac‐specific heart failure biomarkers: is Dickkopf‐3 (DKK3) a possible candidate?
por: Piek, Arnold, et al.
Publicado: (2020)

Epicardial Adipose Tissue and Outcome in Heart Failure With Mid-Range and Preserved Ejection Fraction
por: van Woerden, Gijs, et al.
Publicado: (2021)

Protocol for a randomized study assessing the feasibility of home-based albuminuria screening among the general population: The THOMAS study
por: van Mil, Dominique, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kg3ipj3b5il3v62rda90biu66m